home All News open_in_new Full Article

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that it has secured a strategic investment and that it is evaluating corporate cryptocurrency treasury strategies as part of its broader financial and growth objectives. We […]


today 8 d. ago attach_file Technology

attach_file Society
attach_file Economics
attach_file Technology
attach_file Events
attach_file Science
attach_file Economics


ID: 3505224307
Add Watch Country

arrow_drop_down